Biotechnology Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Biotechnology Market, By Technology

7.1.  Biotechnology Market, by Technology Type, 2020-2030

7.1.1.    Nanobiotechnology

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Tissue Engineering and Regeneration

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    DNA Sequencing

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Cell-based Assays

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Fermentation

7.1.5.1.        Market Revenue and Forecast (2016-2030)

7.1.6.    PCR Technology

7.1.6.1.        Market Revenue and Forecast (2016-2030)

7.1.7.    Chromatography

7.1.7.1.        Market Revenue and Forecast (2016-2030)

7.1.8.    Others

7.1.8.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Biotechnology Market, By Application

8.1.  Biotechnology Market, by Application, 2020-2030

8.1.1.    Health

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Food & Agriculture

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Natural Resources & Environment

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Industrial Processing

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Bioinformatics

8.1.5.1.        Market Revenue and Forecast (2016-2030)

8.1.6.    Others

8.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Biotechnology Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Technology (2016-2030)

9.1.2.    Market Revenue and Forecast, by Application (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Technology (2016-2030)

9.2.2.    Market Revenue and Forecast, by Application (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Technology (2016-2030)

9.3.2.    Market Revenue and Forecast, by Application (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Technology (2016-2030)

9.4.2.    Market Revenue and Forecast, by Application (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by Application (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by Application (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Technology (2016-2030)

9.5.2.    Market Revenue and Forecast, by Application (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by Application (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Technology (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by Application (2016-2030)

Chapter 10.  Company Profiles

10.1.              AstraZeneca

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Gilead Sciences, Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              CELGENE CORPORATION

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Biogen

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Abbott

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Amgen Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Novo Nordisk A/S

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Merck & Co.

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Johnson & Johnson Services, Inc.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Novartis AG

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Sanofi

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

10.12.           F. Hoffmann-La Roche Ltd.

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.12.4.               Recent Initiatives

10.13.           Pfizer, Inc.

10.13.1.               Company Overview

10.13.2.               Product Offerings

10.13.3.               Financial Performance

10.13.4.               Recent Initiatives

10.14.           Lonza

10.14.1.               Company Overview

10.14.2.               Product Offerings

10.14.3.               Financial Performance

10.14.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Report Detail

Proceed To Buy

USD 3500
USD 6000